Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Schneider-Brachert, Wulf (6602825060)"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Helicobacter pylori and the risk of benign and malignant biliary tract disease
    (2002)
    Bulajic, Milutin (7003421663)
    ;
    Maisonneuve, Patrick (7005932083)
    ;
    Schneider-Brachert, Wulf (6602825060)
    ;
    Müller, Petra (7403138722)
    ;
    Reischl, Udo (7005565925)
    ;
    Stimec, Bojan (7003411337)
    ;
    Lehn, Norbert (7006308195)
    ;
    Lowenfels, Albert B. (16223739700)
    ;
    Löhr, Matthias (55605216000)
    6BACKGROUND. The etiology of tumors arising in the biliary tract remains unclear. Several previous studies have detected Helicobacter pylori organisms in bile from patients with gallstones or cholecystitis. The objective of this study was to determine whether there is an association between H. pylori in bile and biliary tract carcinoma. METHODS. The authors used polymerase chain reaction (PCR) assays to detect the presence of H. pylori in the stomach and bile from 89 patients: Sixty-three disease free patients had biliary calculi, 15 patients had carcinoma of the biliary tract, and 11 patients had neither gallstones nor carcinoma. Bile was considered to contain H. pylori only if the results of PCR determinations were positive in two or more samples assayed independently in two separate laboratories. RESULTS. There was a strong association between the presence of H. pylori in the stomach and in the bile (P≤0.01). Biliary H. pylori was associated with age but not with gender, and it was associated strongly with the clinical diagnosis. Patients with gallstones were 3.5 times as likely to have H. pylori in the bile compared with patients in a control group (95% confidence interval [95%Cl], 0.8-15.8; P = 0.100), and H. pylori was 9.9 times more frequent in patients with biliary tract carcinoma compared with patients in the control group (95%Cl, 1.4-70.5; P = 0.022). CONCLUSIONS. There is a strong association between biliary tract carcinoma and H. pylori in bile. If these results are confirmed by prospective studies, H. pylori may be responsible for a significant proportion of malignant biliary tract disease. © 2002 American Cancer Society.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Helicobacter pylori and the risk of benign and malignant biliary tract disease
    (2002)
    Bulajic, Milutin (7003421663)
    ;
    Maisonneuve, Patrick (7005932083)
    ;
    Schneider-Brachert, Wulf (6602825060)
    ;
    Müller, Petra (7403138722)
    ;
    Reischl, Udo (7005565925)
    ;
    Stimec, Bojan (7003411337)
    ;
    Lehn, Norbert (7006308195)
    ;
    Lowenfels, Albert B. (16223739700)
    ;
    Löhr, Matthias (55605216000)
    6BACKGROUND. The etiology of tumors arising in the biliary tract remains unclear. Several previous studies have detected Helicobacter pylori organisms in bile from patients with gallstones or cholecystitis. The objective of this study was to determine whether there is an association between H. pylori in bile and biliary tract carcinoma. METHODS. The authors used polymerase chain reaction (PCR) assays to detect the presence of H. pylori in the stomach and bile from 89 patients: Sixty-three disease free patients had biliary calculi, 15 patients had carcinoma of the biliary tract, and 11 patients had neither gallstones nor carcinoma. Bile was considered to contain H. pylori only if the results of PCR determinations were positive in two or more samples assayed independently in two separate laboratories. RESULTS. There was a strong association between the presence of H. pylori in the stomach and in the bile (P≤0.01). Biliary H. pylori was associated with age but not with gender, and it was associated strongly with the clinical diagnosis. Patients with gallstones were 3.5 times as likely to have H. pylori in the bile compared with patients in a control group (95% confidence interval [95%Cl], 0.8-15.8; P = 0.100), and H. pylori was 9.9 times more frequent in patients with biliary tract carcinoma compared with patients in the control group (95%Cl, 1.4-70.5; P = 0.022). CONCLUSIONS. There is a strong association between biliary tract carcinoma and H. pylori in bile. If these results are confirmed by prospective studies, H. pylori may be responsible for a significant proportion of malignant biliary tract disease. © 2002 American Cancer Society.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Helicobacter pylori in colorectal carcinoma tissue
    (2007)
    Bulajic, Milutin (7003421663)
    ;
    Stimec, Bojan (7003411337)
    ;
    Jesenofsky, Ralf (16199860200)
    ;
    Kecmanovic, Dragutin (6603924519)
    ;
    Ceranic, Miljan (6507036900)
    ;
    Kostic, Nada (7005929779)
    ;
    Schneider-Brachert, Wulf (6602825060)
    ;
    Lowenfels, Albert (16223739700)
    ;
    Maisonneuve, Patrick (7005932083)
    ;
    Löhr, Johannes-Matthias (55665962800)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    PCR in Helicobacter spp. diagnostic in extragastric malignancies of digestive system
    (2012)
    Bulajic, Milutin (7003421663)
    ;
    Panic, Nikola (54385649700)
    ;
    Stimec, Bojan (7003411337)
    ;
    Isaksson, Bengt (56240121700)
    ;
    Jesenofsky, Ralf (16199860200)
    ;
    Schneider-Brachert, Wulf (6602825060)
    ;
    Löhr, Johannes-Matthias (55665962800)
    Recognition of Helicobacter pylori as an important factor in genesis of gastric adenocarcinoma lead to a large number of studies concerning potential role of Helicobacter spp. in the development of extragastric digestive malignancies. The serological studies indicated possible localizations in the digestive system being from interest in enlightening Helicobacter spp. carcinogenic potential. The PCR obtruded itself as a gold standard in proving existence of actual correlation. In this review, the authors have examined studies conducted in the last 10 years examining Helicobacter spp. correlation with extragastric digestive carcinogenesis. Studies have been observed in four groups referring to hepatic carcinoma, bile duct cancer, pancreatic cancer, and colon cancer. The results of these researches have shown that there is a strong correlation between Helicobacter spp. colonization and primary liver tumors as well as bile duct tumors, whereas conclusions made by authors examining pancreatic cancer are contradictory and demands further investigation. No correlation between Helicobacter spp. and colon cancer have been proven. The PCR subtype most widely used in studies included in this review was nested PCR, whereas genes targeted most frequently for amplification are 16S rDNA of Helicobacter spp. and UreA gene or cagA gene of H. pylori. During the last 10 years PCR has proven itself as a sovereign method for Helicobacter spp. diagnostic in extragastric organs in the digestive system. Knowledge and experiences obtained in this domain could be encouraging for researchers in analogous fields of interest. © 2012 Wolters Kluwer Health | Lippincott Williams & Wilkins.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback